NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 112 filers reported holding NEVRO CORP in Q2 2015. The put-call ratio across all filers is 2.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $138,000 | -99.3% | 1,600 | -99.3% | 0.02% | -98.9% |
| Q1 2017 | $20,007,000 | -42.5% | 213,526 | -55.4% | 1.70% | -20.5% |
| Q4 2016 | $34,825,000 | -13.9% | 479,293 | +23.7% | 2.13% | +14.9% |
| Q3 2016 | $40,442,000 | +129.3% | 387,422 | +62.0% | 1.86% | +125.8% |
| Q2 2016 | $17,641,000 | +45.6% | 239,177 | +11.1% | 0.82% | +44.0% |
| Q1 2016 | $12,113,000 | +4.1% | 215,317 | +24.9% | 0.57% | +13.7% |
| Q4 2015 | $11,641,000 | -15.9% | 172,437 | -42.2% | 0.50% | -12.7% |
| Q3 2015 | $13,846,000 | -15.6% | 298,477 | -2.2% | 0.58% | +1.8% |
| Q2 2015 | $16,412,000 | – | 305,341 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |